Dr Eric RobertCONSORTIUM COORDINATORARD 2020 COSMÉTOSCIENCESEric ROBERT is a CNRS senior Scientist at GREMI laboratory, Orléans, France. He has been involved in the development,diagnostics and applications of gas discharge plasmas for light source, micro electronics, X-rays diagnostics, and fromten years in the biomedical technologies. His recent publications concern the physics of plasma jets, the antitumouraction of atmospheric pressure cold plasma jets, the combination of plasma treatment with electrochemotherapy, theuse of plasmas for skin treatment in anti-aging strategies. He is assistant director of the GREMI laboratory, in charge ofthe «plasma for biomedical applications» team, and director of the French network «HAPPYBIO» gathering fourty teamsconnected with the researches on the use of plasmas, pulsed electric field and dynamic phototherapy for biology. He isa board member of the International Society for Plasma Medicine and of the International Plasma Chemistry Society.He was the awardee of the Cosmetic Victories in 2017 for the development of cold plasma technology for cosmetics.PLASMA COSMETIC CONSORTIUMThe “Plasma Cosmetic Consortium” (PCC) consits in an interdisciplinary team gathering plasma physicists, skinbiologists, chemical and biomolecular engineers, pharmacists, electronicians and pulse power engineers all previouslyinvolved in “Plasma Medicine”. Plasma medicine targets the development of innovative therapeutics for challengingdiseases where gas discharges have recently shown to offer tremendous opportunities alone or in combination withmore conventional treatments.Life & Health Sciences 201962The main objective of the PCC is to assess the potentialities of cold plama technology, i.e gas discharges in ambient airat atmospheric pressure and at temperature lower than 40°C, for cosmetic industry.One first challenge was to have a clear vision of the very broad needs and market of cosmetics industry, rangingfrom skin/nails/hair care, cosmetic products extraction/formulation and packaging. Then the aim was to translatethe achievements from Plasma Medicine (specially from plasma dermatology) and plasma technology to Cosmetics.Another objective is to reach safe, non toxic plasma approach offering a new physical vector (such as ultrason, light,mechanical stimulation) for skin care. In this perspective, dedicated plasma applicators, meeting consumers demand,skin tissue models allowing the evaluation of plasma application for skin care (of course banning animal testing), andinnovative plasma-assisted production of cosmetic products and packaging have to be addressed. The PCC consortiumwas formed to answer the all constraints and taking into account all positive assets: the French industrial leadership,the unique status of the Centre Val De Loire region, the Cosmetic Valley network, and the worldwide and continuouslyincreasing market. PPC is working on establishing an international conference focusing on the science and technologyof plasma for cosmetics, initiating a new branch of cold plasma technology for biomedical/biological applicationsand building up and strengthening an international community focused on research and innovation for sustainable,environmentally and user-friendly cosmetic industry.So far, the international consortium was shaped, met two times and experienced numbers of exchanges to define thelist of topics correlated with Plasma Cosmetics, organized the First International Meeting on Plasma Cosmetic Science(IMPCS-1) in Orleans in November 2019, initiated the writing of an opinion paper on “opportunities for plasma-inspiredinnovation in cosmetic biotechnology”, reached a first consensus on the definition of the “Plasma Cosmetic Science”asside other plasma aesthetics approaches based on “hot plasmas” or laser tools, and launched the organisation ofIMPCS-2 in Japan in 2021.
PARTNERSProf. Ihn HanKwang Woon University - KRProf. Vittorio ColomboUniversity of Bologne - ITProf. David B. GravesUniversity of California Berkeley - USDr Catherine GrillonCNRS Orléans - FRDr Jun-Seok OhOsaka City University - JPDr Jean-Michel PouvesleCNRS Orléans - FRDr Endre SziliUniversity of South Australia inAdélaïde - AUProf. Thomas Von WoedtkeLeibniz Institute for Plasma Scienceand Technology - DELife & Health Sciences 201963
Change language